link to RWJMS home page
Banner Image Here

GabelMolly Gabel , MD

Clinical Associate Professor
Deputy Director of the Cancer Institute of New Jersey
Office of Extramural Affairs
Tel: 732-253-3939
Email: gabelmo@cinj.rutgers.edu

Click Here For Clinical Information

 

Education:

    • M.D., University of Massachusetts
    • Residency, Henry Ford Hospital

Academic Appointments:

    • Clinical Associate Professor

Honors/Certificates:

    • 2003 American Medical Group Association Acclaim Award Recipient, Outcomes Research in Prostate Cancer
    • One of the Top Docotors in the 2002 Consumers' Checkbook
    • Caring Physician of the Year Award1997, Henry Ford Health System
    • First Place- Resident Research Competition , Michigan Society Therapeutic Radiology, 1992
    • Certificate of American Board of Radiology (Board Certified)

National Reviewer 2005-present:

    • MAY 2009-PRESENT : GYN ONCOLOGY REVIEWER
    • MAY 2009-PRESENT : ANNUAL ASTRO CONFERENCE
    • JULY 2004-2007: REVIEWER, DEPARTMENT OF DEFENSE, RADIOBIOLOGY STUDY SECTION
    • JULY 2000-PRESENT: REVIEWER, JOURNAL CANCER

NATIONAL COMMITTEE MEMBERSHIPS 2005-present

    • 2013-PRESENT          AMERICAN SOCIETY OF RADIATION ONCOLOGY GUIDELINES COMMITTEE
    • 2013-PRESENT          AMERICAN SOCIETY OF RADIATION ONCOLOGY (QUALITY) MEASURES COMMITTEE

INVITEDF SPEAKER (NATIONAL FORUMS ONLY) 2005-present

    • SEPTEMBER 2014     AMERICAN SOCIETY FOR RADIATION ONCOLOGY ANNUAL     MEETING: SPEAKER AND COURSE DEVELOPER: Measuring Quality with Quality Measures: Coming Very Soon to a Radiation Oncology Practice Near You
    • MARCH 2012       NATIONAL WORKSHOP ON NATIONAL CANCER DATABASE (NCDB) RAPID QUALITY REPORTING SYSTEM: “HOW TO LEVERAGE RQRS DATA TO IMPROVE ACCESS TO CARE, QUALITY AND EFFICIENCY; EXAMPLES FROM NJ HOSPITALS”
    • MAY 2011      NATIONAL CANCER REGISTRARS ANNUAL CONFERENCE: ASKED BY COMMISSION ON CANCER TO PRESENT NEW QUALITY STANDARDS AND HOW TO USE NATIONAL CANCER DATA BASE DATA TO DRIVE PERFORMANCE IMPROVEMENT

Research Interests:

    • Cooperative Group Clinical Trials
    • Clinical Outcomes/ Performance Improvement
    • Health Care Disparities

Clinical Interests:

    • Gynecologic Cancer
    • Brachytherapy
    • Urologic Oncology

Insurance Affiliations:

Selected Peer-Reviewed Publications:

    • George, P, Chandwani, S, Gabel, M, Ambrosone, C, Phoads, G, Bandera, E, Demissie, K. “Racial Differences in Time to Diagnosis and Treatment Initiation for Early Stage Breast Cancer.” Journal of Women’s Health,24(3) 2015.
    • Zhang, M; Chen, T; Kim, L; Nelson, C; Gabel, M; Narra, V; Haffty, B; Yue, N. Three-dimensional dosimetric considerations from different point A definitions in cervical cancer low-dose-rate brachytherapy; Journal of Contemporary Brachytherapy, 2013, 4, 222-226
    • Espinosa A, Gabel M, and Vlahakis P.  “Patient Navigation: How to define metrics that support and justify the nurse navigator position”. Journal of Oncology Navigation and Survivorship, October 2012.
    • Jabbour S , Daroui  P, Moore D  , Licitra E ,  Gabel M ,  Aisner J.  “A Novel Paradigm in the Treatment of Oligometastatic Non-Small Cell Lung Cancer”.  J Thoracic Dis 3:4-9, 2011.
    • Daroui, P, Gabel M,  Khan A, Haffty, BG, Goyal, S. “Utilization of Breast Conserving Therapy in Stage 0, I, II Breast Cancer Patients in New Jersey: An American College of Surgeons National Cancer Data Base (NCDB) Analysis”.  Am J Clinical Oncology, April 2011.
    • Goyal S, Osusky K, Gabel M, Yue N, Narra V. “A Novel Method of Island Blocking in Whole Abdominal Radiotherapy using a Modified Electronic Tissue Compensation Technique”, Medical Dosimetry, Volume: 35, Issue: 3, Pages: 220-225, June 2009.
    • Kearney TJ, Gabel M, August DA.  Lumpectomy Plus Tamoxifen With or Without Irradiation in Older Women.  The American Journal of Oncology Review, March 2005; 4(3):139-146.
    • Leak B, Wei JT, Gabel M, Peabody JO, Menon M, Demers R, Tewari A.  Relevant Patient And Tumor Considerations For Early Prostate Cancer Treatment.  Seminars in Urol Onc.  February 2002; 20(1):39-44.
    • Velanovich V, Gabel M, Walker EM, Doyle TJ, O’Bryan RM, Szymanski W, Ferrar JJ, Lewis FR Jr.  Causes for the Undertreatment of Elderly Breast Cancer Patients: Tailoring Treatments to Individual Patients.  J of Am College of Surg.  January 2000; 194(1):8-13.
    • Gabel M, Kim JH, Kolozsvary A, Khil M. Freytag S.  Selective In Vivo Radiosensitization by 5-Fluorocytosine of Human Colorectal Carcinoma Cells Transduced With the E. Coli Cytosine Deaminase (CD) Gene.  Int J Radiat Oncol Biol Phys. July 1, 1998; 41(4), 883-887.
    • Gabel M, Hilton NE.  Multidisciplinary Breast Cancer Clinics: Do They Work?  Cancer.  June 1997; 79:12, 2380-2384.
    • Kim JH, Khil MS, Kim SH, Rye S, Gabel M.  Clinical and Biological Studies of Estramustine Phosphate as A Novel Radiation Sensitizer.  Int J Radiat Oncol Biol Phys. 1994; 29:555-557.

Recent Abstracts:

    • Narra V, Patel AN, Chen T, Zhang M, Gabel M.  “A novel approach to interstitial brachytherapy planning in the treatment of gynecological malignancies: The RWJ Experience” 2014 American Brachytherapy Society meeting, April 2014.

    • Housri N, Kim S, Haffty BH, Gabel M.   “African Americans Face Significant Delays To Treatment After Diagnosis Of Orophyaryngeal Carcinoma”.  American Society of Radiation Oncology Annual Meeting, 2012.

    • Nelson C, Narra V, Motwani S  and Gabel M.  “CT Image Guidance for Low Dose Rate Brachytherapy for Cervical Cancer: Transitioning from 2D to 3D”.  The World Congress of Brachytherapy (ESTRO) May 2012.

    • Chandwani S,  Gezmu T, Gabel M, MD,  Demissie K. “Elapsed Time Between Initiation and Completion of Radiotherapy for Breast Cancer by Race”, Epidemiology Late Breakers program of the 139th APHA Annual Meeting November 2011.

    • Kim JH, Khil MS, Kim SH, Rye S. Gabel M.  Clinical and Biological Studies of Estramustine Phosphate as a Novel Radiation Sensitizer.  Presented at ASCO, May 1992.